top of page

[Explanation] Patient Case CC: Radiating Chest Pain & P2Y12 Inhibitor Selection - #MEDIGRAM

Welcome to the #MEDIGRAM Patient Case: Chief Compliant Series. Short, concise patient cases to foster thought-provoking questions and to challenge you to ask questions! Make sure to by at the end of the week for explanations for the correct/incorrect answers.

 



 

😱 Patient Case CC: Radiating Chest Pain [Explanation] - #MEDIGRAM




💔 Which P2Y12 inhibitor should be avoided?



Clopidogrel: slow onset of action (~ 2 hours) compared to the less than 30 mins of ticagrelor and prasugrel. It is also extensively metabolized by CYP2C19.


Ticagrelor: BID frequency compared to the daily of the clopidogrel and prasugrel.


Prasugrel: Biggest concern is the contraindication in patients with a hx of stroke or TIA due to the increased risk of bleeding. Caution should also be used in elderly patients.



🔮 Website: www.pharmwyze.com




Social Links: links.pharmwyze.com






PHARMWYZE SITREP Newsletter: https://www.pharmwyze.com/sitrepnewsletter



Not medical advice. Educational purposes only. No relationships to report.



Comments


bottom of page